The Europe Endometriosis Market would witness market growth of 11.4% CAGR during the forecast period (2022-2028).
A laparoscopy is typically used to confirm endometriosis. This little procedure entails making a tiny incision beneath the belly button in the abdominal wall while under anesthesia (umbilicus). To view inside, a laparoscope, a thin telescope-like equipment, is put through the skin. The doctor can see areas of endometriosis.
The main goals of treatment are to reduce the discomfort and heavy periods associated with endometriosis, as well as to increase fertility if it has been impacted. Endometriosis can be treated in a number of ways. If the patient's fertility is unaffected by the endometriosis and the symptoms are moderate, therapy may not be desired. About 3 out of 10 times, endometriosis resolves on its own, and symptoms disappear. If symptoms persist or worsen, the patient can always alter their mind and choose endometriosis treatment.
In order to better the lives of patients and boost the economy, the UK government has allocated £790 million to encourage innovations in novel therapies, diagnostics, and medical technology. To enhance the delivery of health and care in a safe manner and better address health issues like cancer treatment and drug error reduction, £25 million will be allocated for patient safety research. Significant funding pledges to advance research in all regions of the nation level the playing field for innovation and address health disparities. Following significant investment to promote ground-breaking experimental medicine research and expand the UK's response to patient safety problems, patients throughout the nation are expected to benefit from novel new medicines and improved health and care service delivery. This will spur market expansion in the Europe region.
The Germany market dominated the Europe Endometriosis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $146.2 million by 2028. The UK market is anticipated to grow at a CAGR of 10.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 12.2% during (2022 - 2028).
Based on Type, the market is segmented into Superficial Peritoneal Lesion, Endometriomas, and Others. Based on Treatment, the market is segmented into Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.
A laparoscopy is typically used to confirm endometriosis. This little procedure entails making a tiny incision beneath the belly button in the abdominal wall while under anesthesia (umbilicus). To view inside, a laparoscope, a thin telescope-like equipment, is put through the skin. The doctor can see areas of endometriosis.
The main goals of treatment are to reduce the discomfort and heavy periods associated with endometriosis, as well as to increase fertility if it has been impacted. Endometriosis can be treated in a number of ways. If the patient's fertility is unaffected by the endometriosis and the symptoms are moderate, therapy may not be desired. About 3 out of 10 times, endometriosis resolves on its own, and symptoms disappear. If symptoms persist or worsen, the patient can always alter their mind and choose endometriosis treatment.
In order to better the lives of patients and boost the economy, the UK government has allocated £790 million to encourage innovations in novel therapies, diagnostics, and medical technology. To enhance the delivery of health and care in a safe manner and better address health issues like cancer treatment and drug error reduction, £25 million will be allocated for patient safety research. Significant funding pledges to advance research in all regions of the nation level the playing field for innovation and address health disparities. Following significant investment to promote ground-breaking experimental medicine research and expand the UK's response to patient safety problems, patients throughout the nation are expected to benefit from novel new medicines and improved health and care service delivery. This will spur market expansion in the Europe region.
The Germany market dominated the Europe Endometriosis Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $146.2 million by 2028. The UK market is anticipated to grow at a CAGR of 10.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 12.2% during (2022 - 2028).
Based on Type, the market is segmented into Superficial Peritoneal Lesion, Endometriomas, and Others. Based on Treatment, the market is segmented into Oral Contraceptives, Gonadotropin-releasing hormone (GnRH) medicines, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Teva Pharmaceuticals Industries Ltd., Sun Pharmaceutical Industries Ltd., Sanofi S.A., AbbVie, Inc., AstraZeneca PLC, Pfizer, Inc., Merck & Co., Inc., GlaxoSmithKline PLC, Abbott Laboratories, and Consilient Health Limited.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Superficial Peritoneal Lesion
- Endometriomas
- Others
By Treatment
- Oral Contraceptives
- Gonadotropin-releasing hormone (GnRH) medicines
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Teva Pharmaceuticals Industries Ltd
- Sun Pharmaceutical Industries Ltd
- Sanofi S.A
- AbbVie, Inc
- AstraZeneca PLC
- Pfizer, Inc
- Merck & Co., Inc
- GlaxoSmithKline PLC
- Abbott Laboratories
- Consilient Health Limited
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Endometriosis Market, by Type
1.4.2 Europe Endometriosis Market, by Treatment
1.4.3 Europe Endometriosis Market, by Distribution Channel
1.4.4 Europe Endometriosis Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Endometriosis Market by Type
3.1 Europe Superficial Peritoneal Lesion Market by Country
3.2 Europe Endometriomas Market by Country
3.3 Europe Others Market by Country
Chapter 4. Europe Endometriosis Market by Treatment
4.1 Europe Oral Contraceptives Market by Country
4.2 Europe Gonadotropin-releasing hormone (GnRH) medicines Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Endometriosis Market by Distribution Channel
5.1 Europe Hospital Pharmacy Market by Country
5.2 Europe Retail Pharmacy Market by Country
5.3 Europe Online Pharmacy Market by Country
Chapter 6. Europe Endometriosis Market by Country
6.1 Germany Endometriosis Market
6.1.1 Germany Endometriosis Market by Type
6.1.2 Germany Endometriosis Market by Treatment
6.1.3 Germany Endometriosis Market by Distribution Channel
6.2 UK Endometriosis Market
6.2.1 UK Endometriosis Market by Type
6.2.2 UK Endometriosis Market by Treatment
6.2.3 UK Endometriosis Market by Distribution Channel
6.3 France Endometriosis Market
6.3.1 France Endometriosis Market by Type
6.3.2 France Endometriosis Market by Treatment
6.3.3 France Endometriosis Market by Distribution Channel
6.4 Russia Endometriosis Market
6.4.1 Russia Endometriosis Market by Type
6.4.2 Russia Endometriosis Market by Treatment
6.4.3 Russia Endometriosis Market by Distribution Channel
6.5 Spain Endometriosis Market
6.5.1 Spain Endometriosis Market by Type
6.5.2 Spain Endometriosis Market by Treatment
6.5.3 Spain Endometriosis Market by Distribution Channel
6.6 Italy Endometriosis Market
6.6.1 Italy Endometriosis Market by Type
6.6.2 Italy Endometriosis Market by Treatment
6.6.3 Italy Endometriosis Market by Distribution Channel
6.7 Rest of Europe Endometriosis Market
6.7.1 Rest of Europe Endometriosis Market by Type
6.7.2 Rest of Europe Endometriosis Market by Treatment
6.7.3 Rest of Europe Endometriosis Market by Distribution Channel
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Product Launches and Product Expansions:
7.3 Sun Pharmaceutical Industries Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Sanofi S.A.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 AbbVie, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Trials and Approvals:
7.6 AstraZeneca PLC
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Trials and Approvals:
7.8 Merck & Co., Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Trials and Approvals:
7.9 GlaxoSmithKline PLC
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Trials and Approvals:
7.9.5.2 Acquisition and Mergers:
7.10. Consilient Health Limited
7.10.1 Company Overview
Companies Mentioned
- Teva Pharmaceuticals Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sanofi S.A.
- AbbVie, Inc.
- AstraZeneca PLC
- Pfizer, Inc.
- Merck & Co., Inc.
- GlaxoSmithKline PLC
- Abbott Laboratories
- Consilient Health Limited
Methodology
LOADING...
